InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Jain Rita, 董事. Director active across 2 companies, notably ChemoCentryx, Inc.. Aggregated, 6 disclosures have been recorded. History available since 21 May 2021. The latest transaction was disclosed on 15 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Rita Jain is a board member and Executive Vice President, Chief Medical Officer at ChemoCentryx, Inc. She brings her medical expertise to guide the strategic and operational decisions of the company.